Latest Whitepapers

This article explores how mRNA and VLP vaccines represent a significant advancement in vaccine technology and will play a role in protection against infectious diseases.

This whitepaper explores the benefits of an automated platform compared to that of traditional Western blotting workflow, highlighting real-life case studies and demonstrating the advantages of multiplexing.

This whitepaper explores innovative chromatography techniques to enhance aggregate removal and improve overall mAb recovery, ensuring higher quality and more effective therapeutic solutions.

Scientists are constantly innovating newer technologies that allow them to understand nuances within these drugs and find ways to manufacture them more reliably.

In this article to learn more about detecting contamination during bioprocessing, contamination’s influence on product quality and safety and emerging methods for detecting microbial contaminations.

This article discusses the use of nanoparticle-based lateral flow assays (LFAs) to detect mycotoxins, enhancing sensitivity, accuracy and speed.

Discover cutting-edge whole-genome sequencing technology that offers unparalleled accuracy and completeness in microbial genome assembly, providing essential insights into pathogen surveillance and antimicrobial resistance.

This whitepaper explores the need for transparency between suppliers and manufacturers, ensuring the integrity of their products and maintaining trust among consumers and regulatory authorities alike.

This whitepaper explores the tools available to characterize antibody binding to Fc receptors, including quantitative assays to support optimization of therapeutic products.

Binding affinity is a significant factor to consider. However, relying solely on affinity can be problematic, as the highest affinity mAbs may not exhibit optimal activity. To ensure the best lead candidates, it is crucial to consider factors like specificity, selectivity and biological relevance.